Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOLEUCOVORIN for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where LEVOLEUCOVORIN was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for LEVOLEUCOVORIN

Side Effect Reports % Deaths Hosp.
Diarrhoea 302 9.5% 35 163
Nausea 274 8.7% 36 127
Neutropenia 246 7.8% 19 50
Decreased appetite 223 7.0% 42 129
Neuropathy peripheral 178 5.6% 12 41
Neutrophil count decreased 176 5.6% 39 88
Pyrexia 175 5.5% 23 126
Vomiting 167 5.3% 19 100
Febrile neutropenia 130 4.1% 28 65
Off label use 125 4.0% 21 36
Fatigue 123 3.9% 26 72
Anaemia 120 3.8% 19 55
White blood cell count decreased 119 3.8% 27 66
Malaise 115 3.6% 11 59
Interstitial lung disease 110 3.5% 59 55

Other Indications for LEVOLEUCOVORIN

Colon cancer (565) Product used for unknown indication (432) Rectal cancer (255) Colorectal cancer metastatic (226) Pancreatic carcinoma (225) Adenocarcinoma of colon (184) Colorectal cancer (107) Rectal adenocarcinoma (79) Gastric cancer (73) Chemotherapy (69)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

LEVOLEUCOVORIN Full Profile All Diffuse large b-cell lymphoma Drugs LEVOLEUCOVORIN Demographics LEVOLEUCOVORIN Timeline